Cargando…
Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study
Low socioeconomic position (SEP) may be associated with adverse outcomes in patients with myelodysplastic syndromes (MDS) inherent to for example, delayed diagnosis or reduced treatment intensity, but firm evidence is limited. In this study, we examined the association between SEP and clinical outco...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087397/ https://www.ncbi.nlm.nih.gov/pubmed/35997314 http://dx.doi.org/10.1002/hon.3068 |
_version_ | 1785022337456799744 |
---|---|
author | Lauritsen, Tine Bichel Østgård, Lene Sofie Granfeldt Grønbæk, Kirsten Dalton, Susanne Oksbjerg Nørgaard, Jan Maxwell |
author_facet | Lauritsen, Tine Bichel Østgård, Lene Sofie Granfeldt Grønbæk, Kirsten Dalton, Susanne Oksbjerg Nørgaard, Jan Maxwell |
author_sort | Lauritsen, Tine Bichel |
collection | PubMed |
description | Low socioeconomic position (SEP) may be associated with adverse outcomes in patients with myelodysplastic syndromes (MDS) inherent to for example, delayed diagnosis or reduced treatment intensity, but firm evidence is limited. In this study, we examined the association between SEP and clinical outcomes. We conducted a population‐based cohort study (2010–2018) of 2233 Danish patients with MDS. SEP measures included individual‐level information on education, cohabitation status and income retrieved from Statistics Denmark. Associations between SEP measures and disease severity at diagnosis were examined using binomial regression analysis. Using time‐to‐event analysis, we examined the association between SEP measures and treatment with allogeneic stem cell transplantation (allo‐HSCT), risk of progression to acute myeloid leukemia (AML), and death. Estimates were adjusted for covariates selected based on direct acyclic graphs and reported with 95% confidence intervals. Patients with a short education were more likely to be transfusion‐dependent at diagnosis (RR = 1.25, 95% CI: 1.04–1.45) and more likely to be diagnosed with higher risk MDS according to the International Prognostic Scoring System (RR = 1.29, 95% CI: 1.03–1.62), than patients with a long education. We found no clear association between SEP and risk of progression to AML. In adjusted models, the 1‐year risk of dying was higher in patients with short versus long education (RR = 1.34, 95% CI: 1.08–1.65), in patients with low versus high income (RR = 1.42, 95% CI: 1.14–1.77), and among patients who lived alone compared to those who lived with a partner (RR = 1.15, 0.98–1.35). These associations persisted after 3 years and 5 years of follow‐up. Notably, patients with a short education had a markedly lower rate of undergoing treatment with allo‐HSCT compared to patients with a long education (HR = 0.51, 95% CI: 0.31–0.84). In conclusion, low SEP and especially short education, were poor prognostic factors for adverse clinical outcomes among patients with MDS. |
format | Online Article Text |
id | pubmed-10087397 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100873972023-04-12 Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study Lauritsen, Tine Bichel Østgård, Lene Sofie Granfeldt Grønbæk, Kirsten Dalton, Susanne Oksbjerg Nørgaard, Jan Maxwell Hematol Oncol Original Articles Low socioeconomic position (SEP) may be associated with adverse outcomes in patients with myelodysplastic syndromes (MDS) inherent to for example, delayed diagnosis or reduced treatment intensity, but firm evidence is limited. In this study, we examined the association between SEP and clinical outcomes. We conducted a population‐based cohort study (2010–2018) of 2233 Danish patients with MDS. SEP measures included individual‐level information on education, cohabitation status and income retrieved from Statistics Denmark. Associations between SEP measures and disease severity at diagnosis were examined using binomial regression analysis. Using time‐to‐event analysis, we examined the association between SEP measures and treatment with allogeneic stem cell transplantation (allo‐HSCT), risk of progression to acute myeloid leukemia (AML), and death. Estimates were adjusted for covariates selected based on direct acyclic graphs and reported with 95% confidence intervals. Patients with a short education were more likely to be transfusion‐dependent at diagnosis (RR = 1.25, 95% CI: 1.04–1.45) and more likely to be diagnosed with higher risk MDS according to the International Prognostic Scoring System (RR = 1.29, 95% CI: 1.03–1.62), than patients with a long education. We found no clear association between SEP and risk of progression to AML. In adjusted models, the 1‐year risk of dying was higher in patients with short versus long education (RR = 1.34, 95% CI: 1.08–1.65), in patients with low versus high income (RR = 1.42, 95% CI: 1.14–1.77), and among patients who lived alone compared to those who lived with a partner (RR = 1.15, 0.98–1.35). These associations persisted after 3 years and 5 years of follow‐up. Notably, patients with a short education had a markedly lower rate of undergoing treatment with allo‐HSCT compared to patients with a long education (HR = 0.51, 95% CI: 0.31–0.84). In conclusion, low SEP and especially short education, were poor prognostic factors for adverse clinical outcomes among patients with MDS. John Wiley and Sons Inc. 2022-09-06 2022-12 /pmc/articles/PMC10087397/ /pubmed/35997314 http://dx.doi.org/10.1002/hon.3068 Text en © 2022 The Authors. Hematological Oncology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Lauritsen, Tine Bichel Østgård, Lene Sofie Granfeldt Grønbæk, Kirsten Dalton, Susanne Oksbjerg Nørgaard, Jan Maxwell Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study |
title | Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study |
title_full | Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study |
title_fullStr | Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study |
title_full_unstemmed | Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study |
title_short | Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study |
title_sort | socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: a population‐based cohort study |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087397/ https://www.ncbi.nlm.nih.gov/pubmed/35997314 http://dx.doi.org/10.1002/hon.3068 |
work_keys_str_mv | AT lauritsentinebichel socioeconomicpositionandclinicaloutcomesinpatientswithmyelodysplasticsyndromesapopulationbasedcohortstudy AT østgardlenesofiegranfeldt socioeconomicpositionandclinicaloutcomesinpatientswithmyelodysplasticsyndromesapopulationbasedcohortstudy AT grønbækkirsten socioeconomicpositionandclinicaloutcomesinpatientswithmyelodysplasticsyndromesapopulationbasedcohortstudy AT daltonsusanneoksbjerg socioeconomicpositionandclinicaloutcomesinpatientswithmyelodysplasticsyndromesapopulationbasedcohortstudy AT nørgaardjanmaxwell socioeconomicpositionandclinicaloutcomesinpatientswithmyelodysplasticsyndromesapopulationbasedcohortstudy |